"Under his leadership, Pfizer made tens of billions in profit from its COVID-19 vaccine, leading to accusations of pandemic profiteering from groups like Oxfam and Global Justice Now."

Source: Company Financial Reports

"Pfizer was heavily criticized by global health advocates for its pricing strategy and for prioritizing vaccine sales to wealthy nations, a situation critics labeled "vaccine apartheid"."

Source: Amnesty International

"He has been a staunch opponent of waiving intellectual property (IP) rights for the COVID-19 vaccine, arguing it would not solve supply issues and would stifle future innovation."

Source: World Trade Organization

"After the US government stopped buying the COVID-19 antiviral drug Paxlovid, Pfizer set a high commercial price for it, drawing condemnation from politicians like Bernie Sanders."

Source: US Senate Hearings

"Bourla sold $5.6 million worth of his Pfizer stock on the same day the company announced positive results for its COVID-19 vaccine, drawing criticism over the timing of the pre-scheduled trade."

Source: SEC Filings

"Pfizer is consistently one of the largest lobbying spenders in Washington D.C., using its immense influence to fight government efforts to lower prescription drug prices."

Source: OpenSecrets.org

"Pfizer has a history of major marketing scandals, including the record $2.3 billion fine in 2009 for illegally marketing the painkiller Bextra and other drugs."

Source: Department of Justice